China NMPA Product Recall - Ventilator

On October 17, 2019, Philips (China) Investment Co., Ltd. initiated a voluntary Class II recall of specific ventilators, as reported by the National Medical Products Administration (NMPA). The recall stems from a critical issue identified in some Philips V60 ventilators where the touchscreen may become unresponsive. This malfunction directly impacts patient care by preventing users from adjusting crucial treatment settings, such as FiO2, which could pose a risk to patients. While the unresponsiveness of the touchscreen is immediately detectable, users receive no prior warning regarding the impending failure. This voluntary action, detailed under Shanghai Food and Drug Administration Medical Device Registration Certificate 2019-251, requires the company to retrieve affected devices, identified by Registration Certificate No.: 20163545139. Further comprehensive details regarding the specific models, specifications, and batch numbers of the recalled products are available in an associated 'Medical Device Recall Event Report Form' that accompanies the announcement. This proactive measure by Philips aims to mitigate potential patient safety concerns arising from the identified device malfunction.